Hydration Pharmaceuticals Company LimitedASX: HPC

Letter to UMP Shareholders and Retention Form

Oct 22, 2026 at 6:12 PM EDT · Issued by Hydration Pharmaceuticals Company Limited via ASX

Filed with ASX · Oct 22, 2026 at 6:12 PM EDT

On 6ix: 6ix.com/news/letter-to-ump-shareholders-and-retention-form

743 Prospect Street La Jolla CA 92037 23 October 2026 Dear Shareholder IMPORTANT NOTICE Sale of your Unmarketable Parcel of The Hydration Pharmaceuticals Company Limited Shares The Hydration Pharmaceuticals Company Limited (ACN 620 385 677) (ASX: HPC) (HPC or the Company) has established a share...

View Attachment

6ix hasn’t read this filing yet.

Hydration Pharmaceuticals Company Limited on 6ix

Earlier from Hydration Pharmaceuticals

Prospectus - Non Renounceable Rights IssueOct 22
Rights Issue and UMP Share Sale FacilityOct 22
Results of Extraordinary General MeetingOct 7
July and August 2026 Trading UpdateSep 28
Letter to Shareholders regarding EGMSep 1

Later from Hydration Pharmaceuticals

Proposed issue of securities - HPCOct 22
Change in substantial holdingOct 26
Becoming a substantial holderOct 27
Q3 FY26 Quarterly Activities Report (App 4C)Oct 29
Rights Offer - Despatch of ProspectusNov 1

All Hydration Pharmaceuticals news releases

Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.

Follow Hydration Pharmaceuticals